J.P. Morgan on Wednesday launched its coverage of ANI Pharmaceuticals (NASDAQ:ANIP) with an Overweight recommendation and a ...
Actor and philanthropist Sonu Sood has spoken out in support of newcomers in the film industry amid growing online criticism ...
Does storing copyrighted material amount to infringement? Read what the amicus curiae in the ANI vs OpenAI case said about ...
Fintel reports that on March 14, 2025, Jefferies initiated coverage of ANI Pharmaceuticals (NasdaqGM:ANIP) with a Buy ...
US President Donald Trump on Saturday (local time) announced “decisive and powerful” military action against Yemen’s Houthi ...
The jewelry company owes Love $6 million in royalties, and more than $200,000 in unpaid consulting fees, the suit says.
ANI’s legal battle with OpenAI intensifies as it argues that AI models harm its business by diluting the market for licensed ...
Jefferies initiated coverage of ANI Pharmaceuticals (ANIP) with a Buy rating and $80 price target The firm expects continued momentum for the ...
But “Anora” isn’t quite so easily boiled down: Thanks to lead actress winner Mikey Madison (Ani) — and many scenes with her ...
This year's best picture winner at the Oscars starts out as a kind of romantic comedy, but things get real pretty quick.
Addressing the legal implications of public accessibility, Advocate Ramanujan argued that the mere availability of content in ...
JPMorgan initiated coverage of ANI Pharmaceuticals (ANIP) with an Overweight rating and $85 price target ANI is a specialty pharmaceuticals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results